Comparison of the Efficacy and Safety of 4 vs. 8 Treatments With Tepezza (Teprotumumab) for Thyroid Eye Disease

NCT07308964 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

40

Enrollment

OTHER_GOV

Sponsor class

Conditions

Thyroid Eye Disease
Thyroid Eye Disease, TED
Thyroid Eye Disease (TED)

Interventions

DRUG: Teprotumumab Injection [Tepezza]

Sponsor

Sheba Medical Center